Total Payments
$17,117
2024 Payments
$1,605
Companies
57
Transactions
855
Medicare Patients
7,995
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$13,281 (77.6%)
Other$3,675 (21.5%)
Education$160.92 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,281 | 836 | 77.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,675 | 3 | 21.5% |
| Education | $160.92 | 16 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Esperion Therapeutics, Inc. | $3,851 | 10 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,429 | 109 | $0 (2024) |
| Novo Nordisk Inc | $1,342 | 105 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,145 | 91 | $0 (2024) |
| Amarin Pharma Inc. | $1,014 | 63 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $917.04 | 58 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $804.93 | 44 | $0 (2023) |
| United Therapeutics Corporation | $608.99 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $564.51 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $525.69 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,605 | 92 | AstraZeneca Pharmaceuticals LP ($280.94) |
| 2023 | $1,409 | 75 | Kestra Medical Technology Services, Inc. ($224.79) |
| 2022 | $2,362 | 150 | Novartis Pharmaceuticals Corporation ($281.86) |
| 2021 | $6,106 | 167 | Esperion Therapeutics, Inc. ($3,812) |
| 2020 | $1,366 | 87 | Amarin Pharma Inc. ($300.82) |
| 2019 | $1,139 | 82 | Novo Nordisk Inc ($242.19) |
| 2018 | $1,686 | 103 | Novo Nordisk Inc ($238.89) |
| 2017 | $1,445 | 99 | United Therapeutics Corporation ($338.89) |
All Payment Transactions
855 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | NEXIUM (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Gastrointestinal | ||||||
| 11/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $39.04 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/19/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: Cardiovascular | ||||||
| 09/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,898 | 2,791 | $486,287 | $229,568 |
| 2022 | 21 | 1,922 | 3,059 | $544,720 | $275,925 |
| 2021 | 21 | 2,169 | 3,071 | $539,268 | $271,540 |
| 2020 | 20 | 2,006 | 3,094 | $501,776 | $239,631 |
Total Patients
7,995
Total Services
12,015
Medicare Billing
$1.0M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 313 | 546 | $106,470 | $66,929 | 62.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 354 | 636 | $95,400 | $60,979 | 63.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 289 | 296 | $118,104 | $38,884 | 32.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 251 | 253 | $99,176 | $34,835 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $7,128 | $4,387 | 61.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 307 | 377 | $12,441 | $3,951 | 31.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 23 | 24 | $9,624 | $3,433 | 35.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 21 | $5,586 | $2,953 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 39 | $3,354 | $2,406 | 71.7% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 19 | 19 | $5,681 | $1,594 | 28.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 11 | 11 | $2,134 | $1,424 | 66.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 21 | $2,037 | $1,348 | 66.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 43 | 86 | $2,150 | $1,246 | 57.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 28 | $1,512 | $1,141 | 75.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 28 | 43 | $7,009 | $1,119 | 16.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 16 | 100 | $2,000 | $817.02 | 40.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 17 | 134 | $938.00 | $562.80 | 60.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 26 | 27 | $1,672 | $447.60 | 26.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 22 | 26 | $1,014 | $305.71 | 30.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 14 | 14 | $840.00 | $266.63 | 31.7% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 26 | 27 | $1,036 | $219.57 | 21.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 13 | $351.00 | $202.40 | 57.7% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 14 | 14 | $630.00 | $115.94 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 406 | 1,017 | $198,315 | $136,729 | 68.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 310 | 315 | $125,685 | $45,652 | 36.3% |
About Dr. Mark Rasak, DO
Dr. Mark Rasak, DO is a Cardiovascular Disease healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053391920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Rasak, DO has received a total of $17,117 in payments from pharmaceutical and medical device companies, with $1,605 received in 2024. These payments were reported across 855 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($13,281).
As a Medicare-enrolled provider, Rasak has provided services to 7,995 Medicare beneficiaries, totaling 12,015 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Livonia, MI
- Active Since 01/18/2006
- Last Updated 01/17/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1053391920
Products in Payments
- NEXLIZET (Drug) $3,745
- XARELTO (Drug) $1,134
- Vascepa (Drug) $1,014
- ENTRESTO (Drug) $840.22
- MULTAQ (Drug) $688.35
- Saxenda (Drug) $620.19
- LEQVIO (Drug) $588.28
- ELIQUIS (Drug) $541.87
- JARDIANCE (Drug) $534.42
- ORENITRAM (Drug) $509.70
- VERQUVO (Drug) $447.67
- Belviq (Drug) $426.47
- Ozempic (Drug) $278.17
- Repatha (Biological) $270.44
- LifeVest (Device) $252.82
- PRADAXA (Drug) $248.32
- iPro2 (Device) $231.79
- Assure WCD (Device) $224.79
- BRILINTA (Drug) $184.11
- Corlanor (Drug) $177.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Livonia
Dr. Salwan Anton, D.o, D.O
Cardiovascular Disease — Payments: $27,884
Cardiovascular Disease $27,884
Dr. Robert Grodman, D.o, D.O
Cardiovascular Disease — Payments: $15,817
Cardiovascular Disease $15,817
Dr. Andrew Borin, Do, DO
Cardiovascular Disease — Payments: $8,050
Cardiovascular Disease $8,050
Dr. Jowher Khaleel, M.d, M.D
Cardiovascular Disease — Payments: $3,383
Cardiovascular Disease $3,383
Barry Lewis, Do, DO
Cardiovascular Disease — Payments: $883.28
Cardiovascular Disease $883.28
Dr. Jose Evangelista, M.d, M.D
Cardiovascular Disease — Payments: $423.85
Cardiovascular Disease $423.85